292 related articles for article (PubMed ID: 27263039)
1. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
2. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
3. Combined oral contraceptive use among women with hypertension: a systematic review.
Curtis KM; Mohllajee AP; Martins SL; Peterson HB
Contraception; 2006 Feb; 73(2):179-88. PubMed ID: 16413848
[TBL] [Abstract][Full Text] [Related]
4. Progestin-only contraception and thromboembolism: A systematic review.
Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
[TBL] [Abstract][Full Text] [Related]
5. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.
Steenland MW; Zapata LB; Brahmi D; Marchbanks PA; Curtis KM
Contraception; 2013 May; 87(5):611-24. PubMed ID: 23177264
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
Hannaford P
Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
[TBL] [Abstract][Full Text] [Related]
8. Safety of hormonal contraceptives among women with migraine: A systematic review.
Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraceptives for contraception in overweight or obese women.
Lopez LM; Grimes DA; Chen M; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
Cochrane Database Syst Rev; 2013 Apr; (4):CD008452. PubMed ID: 23633356
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure measurement prior to initiating hormonal contraception: a systematic review.
Tepper NK; Curtis KM; Steenland MW; Marchbanks PA
Contraception; 2013 May; 87(5):631-8. PubMed ID: 23063336
[TBL] [Abstract][Full Text] [Related]
13. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Ramanadhan S; Hansen K; Henderson JT; Cohen MA; Paynter R; Edelman A
Cochrane Database Syst Rev; 2023 May; 5(5):CD014908. PubMed ID: 37184292
[TBL] [Abstract][Full Text] [Related]
14. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
15. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
18. Contraception, venous thrombosis and biological plausability.
Rott H
Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
[TBL] [Abstract][Full Text] [Related]
19. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
20. Combined oral contraceptives, smoking, and cardiovascular risk.
Farley TM; Meirik O; Chang CL; Poulter NR
J Epidemiol Community Health; 1998 Dec; 52(12):775-85. PubMed ID: 10396518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
